Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — Mounjaro is licensed and prescribed as a once-weekly injection, and extending that to every two weeks is not supported by the medicine's UK licence or its clinical evidence. The dosing schedule exists because tirzepatide's active levels in the body are calibrated for a seven-day cycle; stretching to 14 days leaves a meaningful gap in coverage. These are prescription-only medicines, and any changes to how often you inject must be discussed with your prescriber, never adjusted on your own.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide has a half-life of roughly five days. That means, after each injection, drug levels rise, peak, then gradually fall before the next weekly dose brings them back up. The result is a relatively stable therapeutic range across the seven days, enough for appetite suppression and the metabolic effects to be consistent. Stretch that to 14 days and levels drop considerably in the second week, potentially undermining the medicine's core purpose.
The NHS medicines guidance for tirzepatide is clear that Mounjaro is taken once weekly, on the same day each week where possible. The SURMOUNT clinical trials (which produced the weight-loss evidence that underpins the UK licence) were built entirely around weekly dosing. There is no comparable data for fortnightly use.
It's also worth understanding that the starting dose of 2.5mg serves a specific purpose: settling your system before the dose rises. That calibration depends on a weekly rhythm, and if you have found yourself wondering whether taking Mounjaro every five days is a workable alternative, altering the frequency disrupts it in ways a prescriber cannot predict without clinical data to guide them.
If you realise you have missed your usual injection day, the standard advice is to take it as soon as you remember, but only if the next scheduled dose is still at least four days away. If fewer than four days remain, skip the missed dose and continue from your next usual day. You would not simply switch to every two weeks; you would return to the weekly schedule.
This guidance comes directly from Mounjaro's Patient Information Leaflet, which every patient should have read before starting treatment. A practical checking habit worth building: keep the leaflet tucked inside the box in your fridge and glance at the missed-dose section whenever your routine is disrupted. It takes under a minute and removes the temptation to improvise.
What you should not do is adjust your injection frequency independently. The interaction between dosing intervals, titration timing, and side-effect risk is exactly the kind of thing that warrants a clinical conversation. Our aftercare team is available seven days a week for questions like this.
Not under the current UK licence. Mounjaro holds a marketing authorisation for weight management and type 2 diabetes in adults, and both indications specify weekly subcutaneous injection. Your prescriber at a regulated UK service like nume prescribes within that authorisation, they cannot simply re-write the schedule.
There are situations where a prescriber might pause treatment temporarily (planned surgery, pregnancy concerns, a period of illness), but pausing is different from halving the frequency as a standing arrangement. If you are wondering whether every-two-weeks dosing might suit you because of cost, side effects, or practical difficulty, each of those is a genuine clinical conversation, not a self-adjustment. You can read more about how the dosing intervals are handled in our frequently asked questions.
Some readers arrive at this question after reading about different interval ideas online, every five days, every six days, every eight days. None of these are licensed approaches. Our page on taking Mounjaro every other week addresses the fortnightly question from a slightly different angle if you want further detail. For those curious about shorter intervals, if you have found yourself wondering whether taking Mounjaro every six days is an option, the answer follows similar logic, not supported by the evidence base.
Plenty of people find the weekly habit harder to maintain than they expected. Work travel, shift patterns, needle anxiety, or simply forgetting, these are common. None of them are solved by doubling the gap between doses, but most of them have practical answers.
Changing your injection day is usually simple: your prescriber can advise on the minimum gap needed to shift it forward or back. Needle anxiety is something our clinical team hears about regularly, the KwikPen's mechanism, where the needle is concealed, helps many people. For those still weighing whether Mounjaro is the right fit at all, the weight-loss treatment overview sets out all licensed options.
If cost is the underlying concern, it is worth reading about what's included in Mounjaro treatment through a regulated service before drawing conclusions. The full Mounjaro guide also covers eligibility, how titration works in practice, and what to expect from the first few months. And for anyone considering treatment but unsure whether they qualify, checking your BMI against Mounjaro's eligibility criteria is a sensible first step.
If you are already on treatment and finding the weekly schedule difficult, the right move is a conversation with a prescriber, not a change made independently. You can check your eligibility and start a free consultation if you haven't begun treatment yet, or reach out to our clinical aftercare team if you are mid-treatment and need support.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.